$250 | Single User
$500 | Site License
$750 | Enterprise License

Dishman Pharmaceuticals and Chemicals Ltd (DISHMAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Published by Global Data: 25 Nov 2016 | 38411 | In Stock

Introduction

Summary

Dishman Pharmaceuticals and Chemicals Ltd (Dishman) is a pharmaceutical company that develops, manufactures and supplies Active Pharmaceutical Ingredients (API). The company offers a portfolio of development, scale-up and manufacturing services. The company’s product portfolio includes specialty chemicals; vitamins and chemicals; and disinfectants. Dishman’s specialty chemicals includes phase transfer catalysts, APIs, intermediates and fine chemicals; vitamins and chemicals include vitamin D2, vitamin D3 and vitamin D analogues; and disinfectants include antiseptic and disinfectant formulations among others. It also offers services such as contract research, contract manufacturing and API supply. It has its operations in India, China, Japan, the Netherlands, Switzerland, the UK and the US. Dishman is headquartered in Ahmedabad, Gujarat, India.

Dishman Pharmaceuticals and Chemicals Ltd (DISHMAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Dishman Pharmaceuticals and Chemicals Ltd (DISHMAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

    Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

    Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

    Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

    Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9

    Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deal Details 10

    Partnerships 10

    Carbogen Amcis Enters Into Agreement With ADC Biotechnology To Offer Development And Manufacturing Services 10

    CARBOGEN AMCIS Enters Into Collaboration With Polymun Scientific Immunbiologische Forschung 11

    Carbogen Amcis And EirGen Pharma Enter Into Partnership 12

    Licensing Agreements 13

    Dishman Pharma Enters into Licensing Agreement with Janssen Pharma 13

    Redx Pharma Enters Into Licensing Agreement With Dishman For Prescription Drug Technology 14

    Debt Offering 15

    Dishman Pharma Completes Private Placement Of Debentures For US.4 Million 15

    Asset Transactions 16

    Dishman Pharma and Chemicals Plans To Sell China Plant 16

    Acquisition 17

    CARBOGEN AMCIS Acquires Creapharm Parenterals From Creapharm 17

    Dishman Pharmaceuticals and Chemicals Ltd - Key Competitors 18

    Key Employees 19

    Locations And Subsidiaries 20

    Head Office 20

    Other Locations & Subsidiaries 20

    Appendix 22

    Methodology 22

    About GlobalData 22

    Contact Us 22

    Disclaimer 22

List Of Tables
in Dishman Pharmaceuticals and Chemicals Ltd (DISHMAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Tables

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Dishman Pharmaceuticals and Chemicals Ltd, Deals By Therapy Area, 2010 to YTD 2016 8

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9

Carbogen Amcis Enters Into Agreement With ADC Biotechnology To Offer Development And Manufacturing Services 10

CARBOGEN AMCIS Enters Into Collaboration With Polymun Scientific Immunbiologische Forschung 11

Carbogen Amcis And EirGen Pharma Enter Into Partnership 12

Dishman Pharma Enters into Licensing Agreement with Janssen Pharma 13

Redx Pharma Enters Into Licensing Agreement With Dishman For Prescription Drug Technology 14

Dishman Pharma Completes Private Placement Of Debentures For US.4 Million 15

Dishman Pharma and Chemicals Plans To Sell China Plant 16

CARBOGEN AMCIS Acquires Creapharm Parenterals From Creapharm 17

Dishman Pharmaceuticals and Chemicals Ltd, Key Competitors 18

Dishman Pharmaceuticals and Chemicals Ltd, Key Employees 19

Dishman Pharmaceuticals and Chemicals Ltd, Other Locations 20

Dishman Pharmaceuticals and Chemicals Ltd, Subsidiaries 20

List Of Figures, Charts and Diagrams
in Dishman Pharmaceuticals and Chemicals Ltd (DISHMAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Figures

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Dishman Pharmaceuticals and Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

Additional Details

Publisher

Global Data

Publisher Information

Reference

38411 | GDPH80629D

Number of Pages

22

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Dishman Pharmaceuticals and Chemicals Limited (DISHMAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryDishman Pharmaceuticals and Chemicals Limited (Dishman) is a pharmaceutical company that deve...
06 May 2016 by Global Data USD $250 More Info
Dishman Pharmaceuticals and Chemicals Limited (DISHMAN) - Financial and Strategic SWOT Analysis Review
SummaryDishman Pharmaceuticals and Chemicals Limited (Dishman) is a pharmaceutical company that deve...
15 Apr 2016 by Global Data USD $300 More Info
Dishman Pharmaceuticals and Chemicals Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $350 More Info
Dishman Pharmaceuticals and Chemicals Limited (DISHMAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryDishman Pharmaceuticals and Chemicals Limited (Dishman) is a pharmaceutical company that deve...
10 Mar 2016 by Global Data USD $250 More Info
Dishman Pharmaceuticals and Chemicals Limited (DISHMAN) - Financial and Strategic SWOT Analysis Review
SummaryDishman Pharmaceuticals and Chemicals Limited (Dishman) is a pharmaceutical company that deve...
09 Jan 2016 by Global Data USD $300 More Info
Dishman Pharmaceuticals and Chemicals Limited (DISHMAN) - Financial and Strategic SWOT Analysis Review
SummaryDishman Pharmaceuticals and Chemicals Limited (Dishman) is a pharmaceutical company that deve...
08 Nov 2015 by Global Data USD $300 More Info

This report is published by Global Data

Download Free Report Summary PDF

Dishman Pharmaceuticals and Chemicals Ltd (DISHMAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data